
13 February 2026, 12:00 - 14:00 GMT+01:00
Webinar
Innovation Norway introduces the new UK Digital Health Advisory Panel: your gateway to opportunities in the UK market. Through three digital meet ups in 2026, Norwegian companies will get expert advice to help shape their growth strategies in the UK market.
Jason Leitch CBE
Professor / Patient safety and Healthcare quality expert / Senior Fellow IHI / Former National Clinical Director Scotland
Nicola Haywood-Cleverly
NED | Strategic Advisor | Transformation Lead. FBCS | CHCIO | LPFEDIP | CEng | MIET | MBA
Norwegian health and life science companies interested in export, collaboration or partnerships in UK and Ireland.
We expect companies to participate in all three meetings to get the full benefit of the programme. The topics and advisors are chosen to give you the best foundation to build a growth plan for the UK market.
Please note that there are limited spaces available for companies, this is to make sure each company get the follow up they need, and to keep the discussions and meetings dynamic. Please register interest and we will get back to you.
As part of the Export Initiative on health Innovation Norway will facilitate three digital meetings with the advisory panel through 2026. Each meeting will include up to four advisors, selected according to their expertise and based on the needs of the Norwegian companies. Participating companies may follow up discussions individually with advisors at their own cost in between the meetings.
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.